FDA Approves COSENTYX Product Under Rare Pediatric Disease Priority Review Voucher

Summary

The FDA has approved the COSENTYX product, which redeems a priority review voucher, following a review of its supplemental application submitted by the manufacturer, following the criteria set by the Federal Food, Drug, and Cosmetic Act.